This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining the endobronchial valve market and a clinician's experience using the Zephyr Valve (Pulmonx) and Spiration Valve (Olympus)

Ticker(s): LUNG, OLYMY

Who's the expert?

Institution: UCLA School of Medicine

  • Professor of Medicine and Pulmonology at UCLA 
  • Medical Director of the Lung Institute at Cedars Sinai who has experience managing patients with the Zephyr and Spiration valve. Sees 200 patients with COPD and emphysema
  • Research interest in pulmonary exercise physiology, hyperinflation, emphysema and non-invasive lung volume reduction in emphysema.

Interview Questions
Q1.

Please describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with COPD and emphysema do you manage?

Added By: ben_admin
Q3.

How many patients have you treated with the Zephyr valve? With the Spiration Valve?

Added By: ben_admin
Q4.

How do you differentiate between the two valves?

Added By: ben_admin
Q5.

What patients are eligible for endobronchial valves?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.